Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.

In conclusion, encephalitis is a rare but possibly fatal adverse event of immune checkpoint inhibitors, and prompt diagnosis and treatment are mandatory.
PMID: 30680206 [PubMed]

Source: Clinical Lung Cancer - January 28, 2019 Category: Cancer & Oncology Authors: Niki M, Nakaya A, Kurata T, Nakahama K, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S Tags: Mol Clin Oncol Source Type: research